Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

Clinical trial NCT04088890 · COMPLETED

Trial details

NCT number: NCT04088890
Sponsor: Matthew Frank
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-ALL B-cell Non Hodgkin Lymphoma DLBCL Follicular Lymphoma Grade 3B

Start date: 2019-09-12
Primary completion: 2024-11-07
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.